Hyperglycemia-triggered ATF6-CHOP pathway aggravates acute inflammatory liver injury by β-catenin signaling
Open Access
- 14 March 2022
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-13
Abstract
Although hyperglycemia has been documented as an unfavorable element that can further induce liver ischemia–reperfusion injury (IRI), the related molecular mechanisms remain to be clearly elaborated. This study investigated the effective manner of endoplasmic reticulum (ER) stress signaling in hyperglycemia-exacerbated liver IRI. Here we demonstrated that in the liver tissues and Kupffer cells (KCs) of DM patients and STZ-induced hyperglycemic mice, the ER stress-ATF6-CHOP signaling pathway is activated. TLR4-mediated pro-inflammatory activation was greatly attenuated by the addition of 4-phenylbutyrate (PBA), one common ER stress inhibitor. The liver IRI in hyperglycemic mice was also significantly reduced after PBA treatment. In addition, deficiency of CHOP (CHOP−/−) obviously alleviates the hepatic IRI, and pro-inflammatory effects deteriorated by hyperglycemia. In hyperglycemic mice, β-catenin expression was suppressed while the ATF6-CHOP signal was activated. In the liver tissues of PBA-treated or CHOP−/− hyperglycemic mice, the expression of β-catenin was restored. Furthermore, CHOP deficiency can induce protection against hyperglycemia-related liver IRI, which was disrupted by the knockdown of β-catenin will cause this protection to disappear. High glucose (HG) treatment stimulated ATF6-CHOP signaling, reduced cellular β-catenin accumulation, and promoted the TLR4-related inflammation of BMDMs. But the above effects were partially rescued in BMDMs with CHOP deficiency or by PBA treatment. In BMDMs cultured in HG conditions, the anti-inflammatory functions of CHOP−/− were destroyed by the knockdown of β-catenin. Finally, chimeric mice carrying WT or CHOP−/− BMDMs by bone marrow transplantation were adopted to verify the above conclusion. The current study suggested that hyperglycemia could trigger ER stress-ATF6-CHOP axis, inhibit β-catenin activation, accelerate inflammation, and deteriorate liver IRI, thus providing the treatment potential for management of sterile liver inflammation in DM patients.Keywords
This publication has 43 references indexed in Scilit:
- Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in MicePLOS ONE, 2013
- RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic MiceDiabetes, 2013
- Acute Hyperglycemic Exacerbation of Lung Ischemia–Reperfusion Injury Is Mediated by Receptor for Advanced Glycation End-Products SignalingAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Regulation of innate immunity by signaling pathways emerging from the endoplasmic reticulumCurrent Opinion in Immunology, 2011
- Biology of Endoplasmic Reticulum Stress in the HeartCirculation Research, 2010
- Acute Hyperglycemia Worsens Hepatic Ischemia/Reperfusion Injury in RatsJournal of Gastrointestinal Surgery, 2009
- The endoplasmic reticulum stress response in immunity and autoimmunityNature Reviews Immunology, 2008
- Role for Activating Transcription Factor 3 in Stress-Induced β-Cell ApoptosisMolecular and Cellular Biology, 2004
- The effect of insulin-dependent diabetes mellitus on outcome of liver transplantationTransplantation, 2002
- NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURYTransplantation, 1993